Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Pharmaceutical Investing
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer Steerable Delivery Sheath for the Company's Amulet Device Pharmaceutical Investing
New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes Pharmaceutical Investing
Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference Pharmaceutical Investing
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes Pharmaceutical Investing
Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation Pharmaceutical Investing
Knight to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere myPath Digital Health App Pharmaceutical Investing
